Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 20, Pages 4794
Publisher
Baishideng Publishing Group Inc.
Online
2016-05-24
DOI
10.3748/wjg.v22.i20.4794
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents
- (2016) Jordan Axelrad et al. Clinical Gastroenterology and Hepatology
- Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
- (2016) Douglas B. Johnson et al. JAMA Oncology
- Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2015) A. Bourrier et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cytokines, IBD, and Colitis-associated Cancer
- (2015) Ralph Francescone et al. INFLAMMATORY BOWEL DISEASES
- Cancers Complicating Inflammatory Bowel Disease
- (2015) Laurent Beaugerie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease
- (2015) Pia Manninen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease
- (2014) Anthony Lopez et al. Clinical Gastroenterology and Hepatology
- Gastrointestinal Malignancy and the Microbiome
- (2014) Maria T. Abreu et al. GASTROENTEROLOGY
- Small Bowel Adenocarcinomas Complicating Crohnʼs Disease Are Associated With Dysplasia
- (2014) Magali Svrcek et al. INFLAMMATORY BOWEL DISEASES
- Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease
- (2014) Nynne Nyboe Andersen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease
- (2014) S. Rajca et al. Journal of Crohns & Colitis
- The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
- (2014) Thergiory Irrazábal et al. MOLECULAR CELL
- Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel Disease
- (2013) Björn Pasternak et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab
- (2013) Jeffrey S. Weber et al. CANCER
- Primary Sclerosing Cholangitis: Diagnosis, Prognosis, and Management
- (2013) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Inflammatory Bowel Disease Is Associated With an Increased Risk of Melanoma: A Systematic Review and Meta-analysis
- (2013) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer
- (2013) Laurent Beaugerie et al. GUT
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- A systematic review of anal squamous cell carcinoma in inflammatory bowel disease
- (2013) A.A.P. Slesser et al. SURGICAL ONCOLOGY-OXFORD
- Effects of Cancer Treatment on Inflammatory Bowel Disease Remission and Reactivation
- (2012) Jordan E. Axelrad et al. Clinical Gastroenterology and Hepatology
- Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
- (2012) Millie D. Long et al. GASTROENTEROLOGY
- Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease
- (2012) Harry Sokol et al. INFLAMMATORY BOWEL DISEASES
- Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents
- (2011) Pauline Raaschou et al. ARTHRITIS AND RHEUMATISM
- TNF inhibitor suppresses bone metastasis in a breast cancer cell line
- (2011) Takahiko Hamaguchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
- (2011) Laurent Peyrin–Biroulet et al. GASTROENTEROLOGY
- Intestinal Inflammation and Cancer
- (2011) Thomas A. Ullman et al. GASTROENTEROLOGY
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
- (2011) M. Castellarin et al. GENOME RESEARCH
- Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?
- (2011) Laurent Beaugerie GUT
- Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
- (2011) Tingting Wang et al. ISME Journal
- Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort Studies
- (2010) Natalia Pedersen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
- (2010) David S. Kotlyar et al. Clinical Gastroenterology and Hepatology
- Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register
- (2010) W. G. Dixon et al. ARTHRITIS CARE & RESEARCH
- Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
- (2010) Anja Strangfeld et al. ARTHRITIS RESEARCH & THERAPY
- Ipilimumab: controversies in its development, utility and autoimmune adverse events
- (2009) Jeffrey Weber CANCER IMMUNOLOGY IMMUNOTHERAPY
- Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
- (2009) Millie D. Long et al. Clinical Gastroenterology and Hepatology
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
- (2009) Aminah Jatoi et al. LUNG CANCER
- Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients
- (2008) Floor Pietersma et al. LEUKEMIA & LYMPHOMA
- Immune escape by Epstein–Barr virus associated malignancies
- (2008) Christian Münz et al. SEMINARS IN CANCER BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started